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INTRODUCTION
The inner cell mass (ICM) of the 3.5 days post coitum (d.p.c.)
mouse blastocyst comprises a pool of pluripotent cells, which
gives rise to all the differentiated cell types that make up the
embryo and adult, and many of the extra-embryonic tissues
(Gardner and Beddington, 1988). By 4.5 d.p.c., the pluripotent
ICM cells that lined the blastocoelic cavity have differentiated
to form primitive endoderm, an extra-embryonic cell lineage
which gives rise to both visceral and parietal endoderm
(Gardner, 1985). From 4.5 d.p.c. to 6.5 d.p.c. the remaining
pluripotent cells, referred to collectively as ‘epiblast’, undergo
extensive proliferation, selective apoptosis and migration to
give rise to a columnar epithelial monolayer of pluripotent cells
termed the primitive ectoderm (Snow, 1977; Coucouvanis and
Martin, 1995). Remodelling of the pluripotent cell population
during this time is accompanied by alterations in gene
expression and differentiation potential (Beddington, 1983;
Gardner and Beddington, 1988; Haub and Goldfarb, 1991;
Rogers et al., 1991). The primitive ectoderm, through the
process of gastrulation, gives rise to the mesoderm, ectoderm
and endoderm of the embryo, germ cells and remaining extra-
embryonic tissue (Gardner and Rossant, 1979). While this
represents the normal course of embryogenesis, considerable
developmental lability is evident from the observation that
destruction of up to 85% of cells within the mouse embryo
prior to organogenesis does not necessarily prevent formation
of a normal embryo (Snow and Tam, 1979). This property is
thought to reside in the capacity of pluripotent cells to
reprogram their development in response to environmental
cues (Smith, 1992). 
A molecular understanding of early mammalian
embryogenesis requires characterisation of the signals that
regulate pluripotent cell biology. This has been complicated
by experimental difficulties associated with direct
experimentation on early mammalian embryos, although
increasing evidence points to a role for visceral endoderm as a
source of signals that regulate pluripotent cell maintenance,
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We have undertaken an in vitro differentiation analysis of
two related, interconvertible, pluripotent cell populations,
ES and early primitive ectoderm-like (EPL) cells, which are
most similar in morphology, gene expression, cytokine
responsiveness and differentiation potential in vivo to ICM
and early primitive ectoderm, respectively. Pluripotent
cells were differentiated in vitro as aggregates (embryoid
bodies) and the appearance and abundance of cell lineages
were assessed by morphology and gene expression.
Differentiation in EPL cell embryoid bodies recapitulated
normal developmental progression in vivo, but was
advanced in comparison to ES cell embryoid bodies, with
the rapid establishment of late primitive ectoderm specific
gene expression, and subsequent loss of pluripotent cell
markers. Nascent mesoderm was formed earlier and more
extensively in EPL cell embryoid bodies, and resulted in the
appearance of terminally differentiated mesodermal cell
types prior to and at higher levels than in ES cell embryoid
bodies. Nascent mesoderm in EPL cell embryoid bodies
was not specified but could be programmed to alternative
fates by the addition of exogenous factors.
EPL cells remained competent to form primitive
endoderm even though this is not the normal fate of
primitive ectoderm in vivo. The establishment of primitive
ectoderm-like gene expression and inability to participate
in embryogenesis following blastocyst injection is therefore
not directly associated with restriction in the ability to form
extra-embryonic lineages. However, the EPL cell embryoid
body environment did not support differentiation of
primitive endoderm to visceral endoderm, indicating the
lack of an inductive signal for visceral endoderm formation
deduced to originate from the pluripotent cells. Similarly,
the inability of EPL cells to form neurons when
differentiated as embryoid bodies was attributable to
perturbation of the differentiation environment and loss of
inductive signals rather than a restricted differentiation
potential. Reversion of EPL cells to ES cells was
accompanied by restoration of ES cell-like differentiation
potential. These results demonstrate the ability of
pluripotent cells to adopt developmentally distinct, stable
cell states with altered differentiation potentials.
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survival, apoptosis and differentiation (Chen et al., 1994;
Coucouvanis and Martin, 1995; Thomas and Beddington,
1996). Pluripotent cell lines (embryonic stem or ES cells) can
be isolated from the pre-implantation mouse embryo and
maintained in the undifferentiated state in vitro (Evans and
Kaufman, 1981; Martin, 1981; Brook and Gardner, 1997).
These cells exhibit gene expression profiles and differentiation
potentials that are consistent with their embryonic origin
(Beddington and Robertson, 1989; Rathjen et al., 1999), and
can be used as a model system for the analysis of pluripotent
cell biology. Factors contained within a conditioned medium,
MEDII, cause specific and uniform differentiation of ES cells
into a novel, morphologically distinct, cell population termed
early primitive ectoderm-like or EPL cells (Rathjen et al.,
1999). Gene expression, cytokine responsiveness and in vivo
differentiation potential indicate that EPL cells are a
pluripotent cell population distinct from ES cells and ICM, and
most similar to embryonic primitive ectoderm following
implantation of the embryo and cavitation of the epiblast, but
prior to 6.0 d.p.c. The ES to EPL cell transition was shown to
be reversible in terms of gene expression and formation of
chimaeras in vivo. Pluripotent cells can therefore be
maintained in vitro in two distinct but interconvertible states,
which are most similar to alternative pluripotent cell
populations of the pre- and post-implantation mouse embryo.
In this paper we describe a comparative analysis of ES and
EPL cell differentiation. The inability of EPL cells to
participate in development following blastocyst injection
(Rathjen et al., 1999), while consistent with their relationship
to early primitive ectoderm (Beddington, 1983), complicates
the analysis of differentiation potential in vivo. For this reason,
differentiation was analysed in embryoid bodies by culture of
ES and EPL cell aggregates in suspension. Embryoid bodies
formed from ES cells have been shown to undergo a
differentiation program that is reminiscent of early mouse
embryogenesis, with the ordered appearance of primitive
endoderm, primitive ectoderm and their differentiated
derivatives (Doetschman et al., 1985; Shen and Leder, 1992).
Analysis of EPL cell differentiation potential was carried out
using EPL cells derived from ES cells cultured for 3 days in
medium containing 50% MEDII. Typically, EPL cells formed
in this way exhibit a 15-fold increase in Fgf5 expression and a
7-fold decrease in Rex1 expression (Rathjen et al., 1999)
compared to ES cells. Uniform expression of Oct4 and Fgf5
within the EPL cell population indicates that these cells
comprise a homogeneous pluripotent cell population. EPL cells
were found to retain pluripotence as assessed by gene
expression and the formation of differentiated embryonic and
extra-embryonic cell types in vitro. EPL cell differentiation
within embryoid bodies reflected the developmental
progression of pluripotent cells in vivo. However, formation of
an alternative differentiation environment within EPL cell
embryoid bodies resulted in the production of an altered profile
of differentiated cell types. Comparative analysis of ES and
EPL cell differentiation revealed differences in the timing and
extent of primitive ectoderm, visceral and parietal endoderm,
mesoderm and neuron formation. ES cell differentiation
potential was regained by EPL cells reverted to ES cells.
Pluripotent cell populations can therefore be maintained in
vitro in distinct, interconvertible developmental states with
alternative differentiation potentials. 
MATERIALS AND METHODS
Cell culture and in vitro differentiation assays
All cultures were incubated in 10% CO2 (in air) at 37 ° C on tissue-
culture grade plasticware (Falcon) pretreated with 0.2% gelatin/PBS.
Routine maintenance of pluripotent cells was performed as outlined
in Rathjen et al. (1999). Feeder independent D3 (Doetschman et al.,
1985), MBL5 (Pease et al., 1990; obtained from Lindsay Williams,
Ludwig Institute, Melbourne, Australia) and E14 (Hooper et al., 1987;
obtained from Anna Michaelska, Murdoch Institute, Melbourne,
Australia) ES cell lines were routinely cultured in ES DMEM
(DMEM high glucose; Gibco BRL) supplemented with 40 mg/ml
gentamycin, 10% foetal calf serum (FCS), 0.1 mM b -mercaptoethanol
( b -ME) and 1 mM L-glutamine, to which COS-1 cell-conditioned
medium containing LIF, equivalent to 105 U/ml LIF (ESGRO;
Amrad), was added at 1% (v/v) (Smith, 1991). The KSF-4 ES cell
line, which constitutively expresses nuclear localised LacZ (Berger et
al., 1995; obtained from Patrick Tam, CMRI, New South Wales,
Australia), was maintained on inactivated primary mouse embryonic
fibroblast feeder layers (Abbondanzo et al., 1993) in DMEM (high
glucose) supplemented with 40 mg/ml gentamycin, 20% FCS, 0.1
mM b -ME, 1 mM L-glutamine and 1% LIF as before. Prior to the
formation of EPL cells, KSF-4 cells were cultured on gelatin-treated
plasticware, in the absence of a feeder layer, for two passages. EPL
cells were formed and reverted as described by Rathjen et al. (1999).
Briefly, EPL cells were formed by the culture of ES cells in ES
DMEM containing 50% MEDII (medium conditioned by human
hepatocellularcarcinoma cell line HepG2; ATCC HB-8065; Rathjen
et al., 1999) and without LIF for 3 days before use in differentiation
experiments. Reverted EPL cells were formed by seeding EPL cells,
formed as above, into ES DMEM supplemented with LIF. Reverted
EPL cells were cultured for 6 days prior to use in differentiation
experiments.
For the majority of experiments detailed here, embryoid bodies
were formed in ES DMEM using the partial trypsinisation method
(Robertson, 1987). Alternatively, embryoid bodies were formed from
a single cell suspension plated at 1 · 105 cells/ml in bacteriological
dishes in ES DMEM, or suspended in a hanging drop of medium (50
m l) at 1.6 · 104 cells/ml on the inside surface of a Petri dish lid. Cell
aggregates formed in suspended drops were transferred to
bacteriological dishes for further culture after 48 hours. Embryoid
bodies were maintained with regular replenishing of medium. Mixed
cell embryoid bodies were formed from a single cell suspension as
previously described, with the two cell populations mixed at the
specified ratio. 
Beating muscle formation was assessed in individual embryoid
bodies plated onto pre-equilibrated agarose plugs (1% agarose in
DMEM equilibrated against ES DMEM for 3 hours at 37°C, 10% CO2
in air in 24-well plates) in ES DMEM. The presence or absence of
beating muscle was assessed at days 4, 6, 8, 10 and 12 by microscopic
examination. Alternatively, the presence of beating muscle and
neurons was assessed in individual embryoid bodies seeded into 24-
well trays at day 6 of development and scored microscopically at days
7, 8, 9, 10 and 12. Neuron identity was confirmed by positive staining
with the neurofilament 200 antibody N-4142 (Sigma; data not shown).
Macrophage formation was assessed in aggregates formed from ES
and EPL cells in ES DMEM. After 48 hours, aggregates were
transferred into 1.25 ml MC medium (0.9% methyl cellulose in
IMDM, 15% FCS, 50 m g/ml ascorbic acid, 4.5 · 10- 4 M a -
monothioglycerol) supplemented with 400 U/ml recombinant mouse
IL-3 (courtesy of Dr T. Gonda, Institute of Medical and Veterinary
Science, Adelaide, Australia) and 10 ng/ml recombinant human M-
CSF (R&D Systems). Colonies were scored for the presence or
absence of macrophages by microscopic examination on days 12, 15
and 18. Macrophage identity was confirmed by morphology when
stained with May-Grünwald-Giemsa stain and by positive staining
J.-a. Lake and others
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with the macrophage-specific antibody F4/80 (Austyn and Gordon,
1981; data not shown).
Retinoic acid (RA) differentiation was carried out by plating cells
in bacteriological dishes, at a density of 1· 105 cells/ml, in ES DMEM
supplemented with 1 m M RA. After 48 hours, aggregates were
transferred to ES DMEM and maintained for 2 days before being
seeded individually or collectively into tissue culture dishes. The
presence of neurons was assessed by microscopic examination 2 days
after seeding. Neuron identity was confirmed by positive staining with
the neurofilament 200 antibody N-4142 (Sigma).
Results consistent with those presented in this manuscript were
obtained using EPL cells derived from a variety of ES cell lines
including D3 (Doetschman et al., 1985), MBL5 (Pease et al., 1990),
KSF-4 (Berger et al., 1995), E14 (Hooper et al., 1987) and E14TG2a
(Hooper et al., 1987), and using alternative methods for embryoid
body formation, including single cell suspension, hanging drop and
partial trypsinisation. Furthermore, the differentiation potential
reported for EPL cells was specifically associated with these cells as
it could not be recapitulated by ES cells that had been spontaneously
differentiated by culture in the absence of LIF, nor by ES cells that
had been cultured in the presence of alternative fractions of MEDII
for equivalent time periods (data not shown). 
Gene expression analysis
RNA was isolated from ES and EPL cells using the method of
Edwards et al. (1985). RNA was isolated from embryoid bodies and
RA-treated aggregates by the method of Chomczynski and Sacchi
(1987). Northern blot hybridisation analysis was performed as
described by Thomas et al. (1995). 32P-labelled DNA probes were
synthesised using either the Gigaprime kit (Bresatec) or Megaprime
kit (Amersham). Riboprobes were synthesised as described by Kreig
and Melton (1987). Whole-mount in situ hybridisation on embryoid
bodies was carried out as described by Rathjen et al. (1999). Probe
fragments used for northern blot analysis and/or in situ hybridisations
were: AFP, linearisation of a plasmid containing a 400 bp EcoRI
fragment encoding the first 350 bp of mouse AFP cDNA in
pBluescript II KS+ with HindIII, followed by transcription with T7
polymerase; Brachyury, linearisation of pSK75 (Herrmann, 1991)
with BamHI and transcription with T7 polymerase; Fgf5, an 800 bp
BamHI/EcoRI fragment derived from a plasmid containing the full-
length Fgf5 cDNA (Hébert et al., 1991); Goosecoid, linearisation of
a plasmid containing 909 bp Goosecoid genomic DNA (Blum et al.,
1992) with HindIII and transcription with T3 polymerase; mGAP,
whole plasmid containing 300 bp of mGAP cDNA sequence (Rathjen
et al., 1990); Nkx2.5, linearisation of plasmid containing 1.6 kb
Nkx2.5 cDNA (Lints et al., 1993) with HindIII and transcription with
T3 polymerase; Oct4, a 462 bp XhoI/HindIII fragment derived from
a plasmid containing Oct4 cDNA (Schöler et al., 1990). Antisense
Oct4 riboprobe was obtained by digestion of the foregoing with
HindIII and transcription with T7 polymerase; SPARC, 570 bp EcoRI
fragment derived from pG43 (Mason et al., 1986); Rex1, 848 bp
EcoRI fragment derived from Rex1-containing plasmid (kindly
provided by Dr Neil Clarke, Department of Genetics, University of
Cambridge).
RNase protection assays were performed as described in Chapman
et al. (1997). A riboprobe for the detection of Sox1 was transcribed
from pR1XSox1, a derivative of plasmid #1022 comprising 1100 bp
of the Sox1 cDNA in Bluescript (obtained from Dr R. Lovell-Badge,
National Institute for Medical Research, Mill Hill, London), from
which an approx. 360 bp EcoRI/XhoI Sox1 fragment was subcloned
into Bluescript KS+. pR1XSox1 was digested with BamHI and
transcribed with T3 RNA polymerase. 
Histological analysis
Embryoid bodies were fixed in 4% paraformaldehyde (PFA) in PBS
at 4° C overnight before embedding in paraffin wax and sectioning as
described in Hogan et al. (1994). Sections were stained with Toluidine
Blue for 10 seconds. Embryoid bodies that had been subjected to
whole-mount staining were fixed in 4% PFA overnight, washed
several times with PBS, 0.1% Tween-20, treated with 100% methanol
for 5 minutes and then isopropanol for 10 minutes. Bodies were then
treated and embedded as described above. 
To detect b -galactosidase activity embryoid bodies were fixed in
0.2% glutaraldehyde in PBS for 15 minutes on ice, washed 3· 15
minutes with detergent rinse (0.1 M phosphate buffer, pH 7.3, 2 mM
MgCl2, 0.01% sodium deoxycholate, 0.02% Nonidet P-40) and
stained in detergent rinse containing 5 mM potassium ferricyanide, 5
mM potassium ferrocyanide and 1 mg/ml X-gal for 2 hours at 37 ° C.
Bodies were then washed 3· with detergent rinse and transferred to
70% ethanol. For sectioning embryoid bodies were dehydrated to
100% ethanol and embedded in paraffin wax as described above. 
Immunological detection 
Alpha fetoprotein (AFP) expression in sectioned embryoid bodies was
carried out essentially as described by Dziadek and Adamson (1978)
with the following modifications. Prior to antibody incubations,
endogenous peroxidase activity was blocked by incubation of the
section in 3% H2O2 in methanol for 30 minutes. Sections were then
incubated with a 1/200 dilution of rabbit anti-AFP (ICN) for 2 hours,
then washed several times with PBS before incubation with 1/200
dilution of HRP-conjugated anti rabbit IgG (Silenus).
RESULTS
Advanced pluripotent cell differentiation in EPL cell
embryoid bodies
A clear morphological difference between ES and EPL cell
embryoid bodies was evident within 4 days of embryoid body
formation. ES cell embryoid bodies comprised a homogeneous
population of round, relatively smooth and ordered aggregates
(Fig. 1A). EPL cell embryoid bodies also formed a
homogeneous population; however, the bodies appeared
irregular and disorganised (Fig. 1B). Sectioning and staining
indicated that while ES cell embryoid bodies exhibited a
regular internal morphology characterised by compacted round
cells (Fig. 1C), reminiscent of undifferentiated pluripotent cells
(Martin et al., 1977), internal cells in EPL embryoid bodies
were loosely packed and heterogeneous, possibly reflecting
differentiation (Fig. 1D; Martin et al., 1977).
The progression from ICM to primitive ectoderm to germ
layer formation can be monitored via alterations in gene
expression both in vivo and during embryoid body
differentiation in vitro (Shen and Leder, 1992). Rex1 is
expressed by ICM and ES cells, and is downregulated in EPL
cells, the primitive ectoderm at 6.0 d.p.c. and during ES cell
differentiation in vitro (Hosler et al., 1989; Rogers et al., 1991;
Rathjen et al., 1999). Fgf5 is not expressed by ICM or ES cells,
but is expressed in EPL cells and the primitive ectoderm prior
to and during gastrulation, and upregulated transiently during
ES cell differentiation in vitro (Hébert et al., 1990; Haub and
Goldfarb, 1991; Hébert et al., 1991). Oct4 is expressed by all
pluripotent cell populations of the embryo, EPL cells and ES
cells, and is downregulated upon differentiation of these cells
in vivo and in vitro (Schöler et al., 1990; Schöler, 1991;
Rathjen et al., 1999). 
Although the expression of Rex1 was found to be
downregulated in both ES and EPL cell embryoid bodies, the
kinetics of Rex1 regulation differed between the two cell
populations. Downregulation to a barely detectable, basal level
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was observed by day 1 in EPL cell embryoid bodies
(Fig. 2). In contrast, a similar level of Rex1 expression
was not observed in ES cell embryoid bodies until day
2, with intermediate levels of expression observed on
day 1 (Fig. 2). Similarly, the kinetics of Fgf5 regulation
differed between embryoid bodies derived from ES or
EPL cells. Fgf5, already expressed in EPL cells, was
upregulated rapidly from day 1 in EPL cell embryoid
bodies to a peak on day 2/3, followed by a marked
decrease in expression on day 4. Upregulation of Fgf5
expression in ES cell embryoid bodies was not
observed until day 3. While expression levels in these
bodies increased further at day 4, they remained below
Fgf5 levels in EPL cell bodies at days 2 and 3. Oct4
expression decreased with time in both ES and EPL cell
embryoid bodies but was downregulated more rapidly in EPL
cell embryoid bodies, with a fourfold decrease seen between
days 3 and 4 (Fig. 2). This decrease in Oct4 expression
followed the highest levels of Fgf5 expression and presumably
reflected differentiation of pluripotent cells within the bodies.
The changes in Rex1, Fgf5 and Oct4 expression observed in
both ES and EPL embryoid body development suggested that
differentiation reflected the events of normal embryogenesis
and proceeded through the formation of late stage primitive
ectoderm. This was consistent with our previous alignment of
ES and EPL cells with pluripotent cell populations occurring
prior to 6.0 d.p.c. Further, the rapid increase in Fgf5 expression
and the earlier onset of differentiation, as detected by the loss
of Oct4 and Fgf5 expression, indicated that pluripotent cell
differentiation within EPL cell embryoid bodies was advanced
compared to ES cell embryoid bodies.
The EPL cell embryoid body environment is non-
permissive for visceral endoderm formation
By 4.5 d.p.c. pluripotent cells exposed to the blastocoelic
cavity have differentiated to form primitive endoderm. The
primitive endoderm gives rise to two distinct endodermal cell
populations, visceral endoderm, which remains in contact with
the epiblast, and parietal endoderm, which migrates away from
the pluripotent cells to form a layer of endoderm adjacent to
the trophectoderm (Gardner, 1985). While others have
analysed extra-embryonic endoderm formation at relatively
late stages (day 9-12) of embryoid body development (Soudais
et al., 1995; Duncan et al., 1997), formation of an outer layer
of endoderm, containing both visceral and parietal endoderm
cells, can be observed in embryoid bodies by day 4 or 5 of
development (Doetschman et al., 1985; Robertson, 1987). This
timing is coincident with formation of primitive ectoderm and
creation of an inner cavity, events that accompany endoderm
specification in the embryo (Coucouvanis and Martin, 1995).
Analysis of endoderm formation at this stage is therefore more
likely to reflect normal embryonic events. 
Formation of parietal and visceral endoderm during EPL and
ES embryoid body development was analysed by SPARC and
AFP expression respectively (Holland et al., 1987; Dziadek
and Adamson, 1978). SPARC expression followed similar
kinetics in ES and EPL cell embryoid bodies, with an
approximately twofold increase over the first 4 days (Fig. 3A).
Whole-mount in situ hybridisation and sectioning of ES and
EPL cell embryoid bodies indicated that SPARC expression
was confined to an outer endodermal cell layer in both ES and
EPL cell embryoid bodies at day 4 (Fig. 3B,C), indicative of
parietal endoderm formation. AFP levels were too low to be
detected during these stages by northern analysis or RNase
protection (Shen and Leder, 1992), so whole-mount in situ
hybridisation of embryoid bodies was used to detect AFP
expression. At day 3, 1% of ES cell embryoid bodies exhibited
discrete patches of AFP expressing cells on their surface. This
level rose to 52.9±9.5% of ES cell embryoid bodies by day 4
(Fig. 3D). Sectioning confirmed that AFP expression was
confined to outer cells and was therefore representative of
visceral endoderm (Fig. 3E). AFP expression could not be
detected on surface or interior cells of EPL cell embryoid
bodies at day 3 or day 4 of embryoid body development (Fig.
3F).
Cell mixing experiments were carried out to determine
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Fig. 1. Morphology of ES and EPL cell embryoid bodies at
day 4 of differentiation. (A,C) Day-4 ES cell embryoid
bodies, (B,D) day-4 EPL cell embryoid bodies. Embryoid
bodies in C and D were sectioned and stained with Toluidine
Blue. Bars: 25 m m (A,B); 15 m m (C,D).
Fig. 2. Expression of pluripotent cell markers, FGF5, Rex1 and Oct4,
in differentiating ES and EPL cell embryoid bodies. Northern blot
analysis was carried out on 20 m g total RNA derived from ES and
EPL cell embryoid bodies at the indicated days of differentiation.
Expression of mGAP was used as a loading control (Rathjen et al.,
1990).
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whether the failure of EPL cells to form visceral endoderm
reflected an inherent restriction in the developmental potential
of these cells or an alteration in the embryoid body
environment. The KSF-4 ES cell line constitutively expresses
a LacZ gene modified to target b -galactosidase protein to the
nucleus (Berger et al., 1995). Analysis of embryoid bodies
formed from KSF-4 ES cells demonstrated formation of
visceral endoderm at levels comparable with D3 ES cells (data
not shown). After passaging in the absence of mouse
embryonic fibroblast feeder cells, KSF-4 ES cells were
cultured for 2 days in MEDII to form KSF-4 EPL cells (EPL
(LacZ+)). Embryoid bodies generated by co-aggregation of a
1:1 ratio of D3 ES cells and EPL (LacZ+) cells were assessed
for visceral endoderm formation by AFP expression at day 4.
ES cell embryoid bodies and EPL (LacZ+) cell embryoid
bodies gave rise to visceral endoderm at levels consistent with
those previously described (65% and 0% of bodies
respectively). Embryoid bodies formed from the mixed cell
population gave rise to visceral endoderm at levels comparable
to ES embryoid bodies (51%). Double staining for b -
Fig. 3. EPL cells form parietal endoderm but not visceral endoderm
when differentiated as embryoid bodies. (A) SPARC expression in
embryoid bodies derived from ES and EPL cells at days 1-4 of
differentiation as determined by northern blot analysis.
(B,C) Sections of day-4 ES (B) and EPL (C) cell embryoid bodies
subjected to whole-mount in situ hybridisation with antisense DIG-
labelled SPARC specific riboprobes. (D,E,F) Whole-mount in situ
hybridisation of day-4 ES (D) and EPL (F) cell embryoid bodies with
antisense DIG-labelled AFP specific riboprobes, and (E) cross-
section of an ES cell embryoid body stained for AFP expression.
(G,H) Day-4 chimeric embryoid bodies formed by mixing 1:1 ES
(LacZ- ) and EPL (LacZ+) cells stained for b -galactosidase activity
(blue, nuclear localised), sectioned and stained for AFP expression
by immunoperoxidase antibody staining (brown). Inset shows a
lower magnification of the embryoid body shown in G. Bars:
12.5 m m (B,C,E); 36 m m (D,F); 8.5 m m (G,H).
Fig. 4. Mesoderm induction occurs in EPL cell embryoid bodies
earlier and at higher levels than in ES cell embryoid bodies. (A) The
expression of Brachyury and goosecoid in ES and EPL cell embryoid
bodies at days 0-4 of differentiation as determined by northern blot
analysis of 20 m g of total RNA. Whole-mount in situ hybridisation of
ES (B,D,F,H) and EPL (C,E,G,I) cell embryoid bodies with antisense
DIG-labelled riboprobes specific for Brachyury (B-E) and Oct4 (F-I)
at day 3 (B,C,F,G) and day 4 (D,E,H,I). Bar, 90 m m. 
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galactosidase activity and AFP expression revealed the
presence of LacZ+ and LacZ- cells within both the internal cell
populations and the visceral endoderm (Fig. 3G,H). Visceral
endoderm, of either ES or EPL cell origin, was located adjacent
to internal cells of ES (LacZ- ) or EPL (LacZ+) cell origin. For
example, visceral endoderm of ES cell origin could be found
adjacent to LacZ+ EPL-derived cells, and vice versa. These
results indicate that EPL cell descendants were competent to
form both embryonic and extra-embryonic cell types, and
suggest that the inability of EPL embryoid bodies to form
visceral endoderm resulted from a deficiency in the embryoid
body environment rather than an inherent developmental
restriction of EPL cells.
EPL cell embryoid bodies are predisposed to the
formation of mesodermal progenitors, which can be
programmed to alternative cell fates
Formation of early mesoderm was monitored by analysing
expression of the early mesodermal markers, brachyury and
goosecoid (Herrmann, 1991; Blum et al., 1992; Fig. 4A).
Consistent with previous reports (Keller et al., 1993; Johansson
and Wiles, 1995), brachyury expression was barely detectable
on days 0-3 of development but was upregulated on day 4 in
ES cell embryoid bodies (Fig. 4A). Goosecoid expression
could not be detected in ES cell embryoid bodies during the
course of this experiment. In contrast, brachyury and
goosecoid expression were upregulated 30- and 6-fold,
respectively, on days 2 and 3 of EPL cell embryoid body
development, followed by 9- (brachyury) and 6.5- (goosecoid)
fold decreases in expression on day 4 (Fig. 4A). In both ES
and EPL cell embryoid bodies the expression of mesodermal
markers immediately preceded decreases in the expression
levels of primitive ectoderm markers Fgf5 and Oct4 (Fig. 2).
Brachyury expression in ES cell embryoid bodies did not reach
the levels seen in EPL cell bodies at day 3/4 even after extended
culture.
Whole-mount in situ hybridisation was used to detect the
extent of brachyury expression within the embryoid body
populations. Brachyury expression was detected in 1% of ES
cell embryoid bodies at day 3 and 16% of bodies at day 4 (Fig.
4B,D). By contrast, 98% and 92% of EPL cell embryoid bodies
exhibited brachyury expression on days 3 and 4, respectively
(Fig. 4C,E). A similar expression pattern was observed with
goosecoid (data not shown). Oct4 expression within ES and
EPL cell embryoid bodies exhibited the expected inverse
correlation with the onset and extent of brachyury expression.
Oct4 expression was relatively uniform throughout ES cell
embryoid bodies on days 3 and 4 (Fig. 4F,H), but patchy within
EPL cell embryoid bodies where mesoderm differentiation had
commenced (Fig. 4G,I). The comparison of markers specific
for nascent mesoderm therefore suggested that EPL cell
embryoid bodies undergo a differentiation program which
results in the earlier appearance and more extensive formation
of mesoderm when compared to ES cell embryoid bodies.
Terminal differentiation of nascent mesoderm was
monitored by the appearance of beating cardiocytes (Fig. 5A,
Doetschman et al., 1985). These were first detected in ES cell
embryoid bodies at day 8 of development (8%) and increased
with time, reaching 36% of bodies at day 12. In EPL cell
embryoid bodies, beating muscle was observed in 14% of
embryoid bodies by day 6, 2 days prior to its appearance in ES
cell embryoid bodies, and increased steadily to 60% by days
10 and 12 of embryoid body development. The proportion of
EPL cell embryoid bodies containing beating muscle was
higher than ES cell embryoid bodies at all time points.
Consistent with this profile, expression of Nkx2.5 (Lints et al.,
1993) was induced earlier in EPL cell embryoid bodies, by day
6 compared to day 8 in ES cell embryoid bodies (Fig. 5B).
Furthermore, while Nkx2.5 expression levels increased in both
ES and EPL cell embryoid bodies to day 12, levels in ES cell
embryoid bodies were approximately threefold below those
observed in EPL cell embryoid bodies throughout this period.
The enhanced ability of EPL cells to form cardiac muscle when
differentiated as embryoid bodies presumably reflects the
increased formation of nascent mesoderm during EPL cell
embryoid body differentiation.
Formation of macrophages in response to exogenous factors
(Wiles and Keller, 1991) was assessed to determine if the
elevated levels of nascent mesoderm in EPL cell embryoid
bodies were developmentally restricted to myogenic lineages
or could be programmed to alternative developmental fates. ES
and EPL cell embryoid bodies were differentiated in MC
medium supplemented with mIL-3 and hM-CSF, and scored
for the presence of macrophages on days 12, 15 and 18 (Fig.
J.-a. Lake and others
Fig. 5. Terminal mesoderm differentiation is enhanced in EPL cell
embryoid bodies compared to ES cell embryoid bodies. (A) The
percentage of ES and EPL cell embryoid bodies containing beating
muscle during days 4-12 of differentiation. The mean percentage and
s.d. were derived from two independent experiments; in each
experiment n=48. (B) Nkx2.5 expression in ES and EPL cell embryoid
bodies at days 4-12 as determined by northern blot analysis on 20 m g
of total RNA. (C) The percentage of ES and EPL cell embryoid bodies
containing macrophages on days 12, 15 and 18 of embryoid body
development. The mean percentage and s.d. were derived from five
independent experiments; n=450.
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5C). On day 12, 32.4% of EPL cell embryoid bodies were
observed to contain macrophages, compared to 4.8% of ES cell
embryoid bodies. On days 15 and 18 the proportion of bodies
containing macrophages had increased to 43% of EPL cell
embryoid bodies and 9-10% of ES cell embryoid bodies.
Consistent with the earlier formation of mesoderm in EPL cell
embryoid bodies, formation of macrophages initiated
approximately 2 days earlier in EPL cell embryoid bodies
compared to ES cell embryoid bodies (data not shown).
Enhanced formation of multiple mesodermal lineages in EPL
cell embryoid bodies suggests that the elevated nascent
mesoderm in these bodies contains a multipotent mesodermal
progenitor which can be programmed to alternative fates in
response to specific environmental cues.
EPL cell embryoid bodies fail to form neural and
ectodermal lineages
Differentiation of ES and EPL cells into ectoderm-derived
lineages was assessed by the presence of neurons within
individual embryoid bodies (Fig. 6A). Neurons were not
detected in either embryoid body population before day 10. On
day 10, 20% of ES cell embryoid bodies contained obvious
neural networks. This rose to 42% by day 16. Neurons were
not detected in embryoid bodies derived from EPL cells on any
of the days assessed.
ES cells and P19 embryonal carcinoma (EC) cells form
neurons when differentiated as aggregates in the presence of
retinoic acid (RA) (Jones-Villeneuve et al., 1982; Bain et al.,
1995). To examine whether the inability of EPL cells to form
neurons when differentiated as embryoid bodies resulted from
an inherent restriction in neuron differentiation capacity, the
ability of EPL cells to differentiate into neurons after
aggregation in the presence of RA was assessed. Individual
RA-treated ES and EPL cell aggregates were scored for the
presence of neurons (Fig. 6B) and found to exhibit similar
frequencies of neuron formation at 63% and 68%, respectively.
This indicated that the lack of neurons within EPL cell
embryoid bodies did not reflect an inherent restriction in the
capacity of EPL cells to form neurons, but an altered embryoid
body environment, which resulted in reduced neural
specification.
Sox1 is expressed in ectodermal cells committed to neural
fate and expression persists in undifferentiated neural
progenitors throughout embryonic development (Pevny et al.,
1998). To investigate the development of neurectoderm within
embryoid bodies, RNA isolated from ES and EPL cell
embryoid bodies on days 5 to 10 of development was assessed
for the presence of Sox1 by RNase protection. Sox1 expression
could be detected in ES cell embryoid bodies during this period
of development, consistent with later differentiation into
neurons. By contrast, no Sox1 expression was observed in EPL
cell embryoid bodies, indicating that these failed to form
neurectoderm or neural progenitors (Fig. 6C). 
Reverted EPL cells regain ES cell differentiation
capability
EPL cells revert to ES cells when cultured in the absence of
MEDII but in the presence of LIF, as assessed by morphology,
gene expression, cytokine responsiveness and ability to
contribute to chimaeras following blastocyst injection (Rathjen
et al., 1999). Reversion to ES cells was demonstrated to occur
in clonal EPL cell populations, suggesting that the ES cells
arise from reversion of EPL cells, not as a consequence of
residual ES cells with an EPL cell population (Rathjen et al.,
1999).
ES cells were differentiated to EPL cells by culture in
MEDII for 2 days, before passaging into ES DMEM containing
LIF to form reverted EPL cells (EPLR). Embryoid bodies were
formed from each cell population and their gene expression
and differentiation compared. Representative results are shown
in Fig. 7. Embryoid bodies derived from EPLR cells were
identical in morphology to ES cell embryoid bodies and could
be distinguished easily from EPL cell embryoid bodies at day
4 (Fig. 1; data not shown). Brachyury expression in EPLR cell
embryoid bodies was similar to that observed for ES cell
embryoid bodies, with expression detected at low levels on day
4 of development and not at high levels on day 2 and 3 as
described for EPL cells. Compared to EPL embryoid bodies,
Fig. 6. EPL cell embryoid bodies fail to form neurons. (A) The
percentage of ES and EPL cell embryoid bodies forming neurons
from days 8-16 of differentiation. The mean percentage and s.d. were
derived from two independent experiments; in each experiment
n=48. (B) The percentage of ES and EPL cell RA-treated aggregates
containing neurons. The mean percentage and s.d. were derived from
four independent experiments; in each experiment n=32. (C) RNase
protection assay of 20 m g RNA from ES and EPL cell embryoid
bodies on days 5 to 10 of development with radiolabelled anti-sense
probes specific for Sox1 and mGAP. Marker lane contains
radiolabelled pUC19/HpaII fragments. 
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which failed to give rise to visceral endoderm, EPLR embryoid
bodies gave rise to visceral endoderm at levels comparable to
ES embryoid bodies (31% and 46%, respectively), as shown
by whole-mount in situ hybridisation. Differentiation of ES and
EPL cell embryoid bodies into beating cardiocytes and neurons
was consistent with the profiles previously described. Analysis
of EPLR embryoid bodies indicated that reversion of EPL to
EPLR cells was accompanied by restoration of high levels of
neuron formation (Fig. 7B) and reduced levels and later
appearance of beating cardiocytes (Fig. 7C). Reverted EPL
cells therefore regain ES cell-like differentiation capacity in
vitro.
DISCUSSION
The use of ES cells as an in vitro model system for the analysis
of development has largely been exploited by differentiation of
ES cells as embryoid bodies. Embryoid body differentiation
recapitulates many aspects of early embryogenesis and
circumvents some difficulties associated with experimental
manipulation of the early embryo. Exploitation of this system
would benefit from the ability to carry out comparative
analyses of alternative differentiation via controlled
perturbation of embryoid body differentiation. Some progress
has been made towards this end through the addition of
exogenous growth factors (Johansson and Wiles, 1995; Keller
et al., 1993; Shen and Leder, 1992) and analysis of genetically
altered ES cells (Lints et al., 1993; Soudais et al., 1995; Robb
et al., 1996) during embryoid body differentiation. An
alternative approach is the comparison of related pluripotent
cell types which show different differentiation potentials in
vitro. Such a system potentially allows the origin, target and
identity of inductive signals controlling developmental events
to be determined, as demonstrated by the investigation of
embryonic cavitation using comparative ES and EC cell
differentiation (Coucouvanis and Martin, 1995).
Alternative differentiation potentials reveal distinct
pluripotent cell states
We demonstrate here that differentiation within embryoid
bodies can be reversibly altered by prior differentiation of ES
cells to an alternative pluripotent cell population, EPL cells.
Like ES cells, EPL cells exhibited pluripotent differentiation
capabilities in vitro and differentiated within embryoid
bodies in a manner consistent with differentiation in the early
embryo, with an ordered appearance of primitive endoderm,
primitive ectoderm, germ layers and terminal cell
differentiation. However, EPL cell differentiation within
embryoid bodies was advanced in comparison with ES cell
embryoid bodies, as indicated by the earlier formation and
differentiation of late-stage primitive ectoderm and the earlier
appearance of terminally differentiated mesoderm
derivatives. This difference is consistent with our suggestion
that, compared to ES cells, EPL cells represent an alternative
pluripotent cell state that succeeds the ICM in
embryogenesis. As predicted for an alternative pluripotent
cell population (Rossant, 1993), reversion of EPL cells to an
ES cell equivalent was accompanied by establishment of ES
cell-like differentiation potential in vitro. This is consistent
with our previous demonstration (Rathjen et al., 1999) that
EPL cell reversion, which can occur in clonal EPL cell lines,
is accompanied by establishment of ES cell gene expression,
and restoration of the ability to contribute to chimaera
formation in vivo. These data establish the fact that
pluripotent cells can exist in at least two developmentally
distinct states, which can be interconverted in response to
environmental signals.
Over 85% of the pre-organogenesis gastrulating egg cylinder
can be destroyed without preventing formation of a normal
foetus (Snow and Tam, 1979). This developmental plasticity is
thought to reside in pluripotent cells of the epiblast that are
capable of reprogramming to overcome restrictions in
developmental potential (Smith, 1992). The reversibility of the
ES to EPL cell transition is the first demonstration that cells
with properties equivalent to epiblast or early primitive
ectoderm cells can revert, or dedifferentiate, to a more
primitive pluripotent cell type in response to environmental
cues, and may provide a cellular basis for the developmental
lability of the early mammalian embryo.
The ability of EPL cells to convert to an ‘ES’ phenotype
appears to be shared by other cells, including primordial germ
cells in culture (Matsui et al., 1992; Resnick et al., 1992).
Reversion of pluripotent cells to a more primitive state may
also underlie the ability of EC cell lines obtained from grafts
of 6.5 d.p.c. embryos to contribute to embryonic development
when reintroduced into host blastocysts (Papaionnou et al.,
1978; Rossant and McBurney, 1982). This reversion may
reflect a more general ability for cell respecification since
neural stem cells have been shown to contribute to the
J.-a. Lake and others
Fig. 7. Reverted EPL cells have a differentiation potential similar to
ES cells when differentiated as embryoid bodies. (A) Northern
analysis of Brachyury expression in embryoid bodies derived from
ES, EPL and EPLR cells at days 1-4 of differentiation. (B) The
percentage of ES, EPL and EPLR cell embryoid bodies exhibiting
neurons during days 7-12 of differentiation; n=36. (C) The
percentage of ES, EPL and EPLR cell embryoid bodies forming
beating muscle from days 7-12 of differentiation; n=36. 
ES                     EPL                  EPLR
563Programming pluripotent cell differentiation
haematopoietic system of sub-lethally irradiated mice
(Bjornson et al., 1999). 
Formation of primitive endoderm derivatives from
pluripotent cells 
In vivo, the extra-embryonic endodermal lineage arises from
ICM of the 4.0 d.p.c. blastocyst with the differentiation of the
pluripotent cells exposed to the blastocoelic cavity into
primitive endoderm. The capacity of pluripotent cells after this
differentiation event to form extra-embryonic endodermal
lineages has not been resolved. Developmental restriction prior
to primitive ectoderm formation is implied by the inability of
microsurgically isolated primitive ectoderm from day 5.0
embryos to regenerate primitive endoderm and derivatives in
vitro (Gardner, 1985). These data are supported by the
observation that day 5.0 primitive ectoderm cells are able to
contribute to foetal soma but unable to contribute to primitive
endoderm/derivatives when reinjected into host blastocysts
(Gardner and Rossant, 1979). However, using alternative
experimental approaches primitive endoderm formation from
later pluripotent cell populations has been observed in vitro and
in vivo. ICM cores isolated from aggregated blastocysts were
capable of regenerating primitive endoderm (Pedersen et al.,
1977), and primitive endoderm has been observed in
teratocarcinomas produced by 6/7 d.p.c. primitive ectoderm
(Damjanov et al., 1987) and in differentiated EC cells derived
from these teratocarcinomas (Martin and Evans, 1975). P19 EC
cells, which exhibit morphology and gene expression
consistent with primitive ectoderm (Rogers et al., 1991;
Mummery et al., 1993), retain the capacity to form primitive
endoderm cell types in vitro (Smith et al., 1987). Furthermore,
primitive ectoderm cells of the 6.5 d.p.c. embryo can be
recruited to the extra-embryonic endoderm cell layer by direct
delamination (Tam and Beddington, 1992).
Efficient formation of parietal endoderm, a derivative of
primitive endoderm, within EPL cell embryoid bodies, with
kinetics similar to ES cell embryoid bodies, indicated that
these cells retained the ability to form primitive endoderm.
Formation of primitive ectoderm therefore appears to be a
complex process in which alterations in gene expression and
ability to form chimaeras following blastocyst injection are not
necessarily accompanied by restriction in the ability to form
primitive endoderm. The ability of EPL cells to form extra-
embryonic lineages is therefore consistent with persistence of
developmental plasticity in pluripotent cells beyond the
acquisition of primitive ectoderm characteristics. Variable
results obtained in earlier experiments may reflect the use of
culture conditions that were not capable of maintaining
primitive ectoderm in vitro, or environments in vivo and in
vitro that were non-permissive or not instructive for primitive
endoderm formation.
An inductive signal for visceral endoderm
differentiation
Although parietal endoderm was formed efficiently in EPL cell
embryoid bodies, they displayed a clear restriction in visceral
endoderm formation. This is intriguing given that experimental
evidence strongly suggests that visceral and parietal endoderm
arise from a common precursor, the primitive endoderm
(Gardner, 1982, 1983, 1985). EPL cells within an ES cell
embryoid body environment were able to form visceral
endoderm, with the appearance of both EPL- and ES-cell-
derived visceral endoderm coincident within the bodies. This
indicates that the failure to form visceral endoderm did not
represent an inherent restriction in EPL differentiation
potential but rather the absence of an appropriate environment
or inductive signal in the EPL embryoid bodies, which is
present in the ES cell embryoid bodies. This signal is unlikely
to originate from parietal endoderm, which is present in both
ES and EPL embryoid bodies, suggesting that induction of
visceral endoderm requires an inductive signal from the
pluripotent cells. A similar conclusion was reached by Gardner
(1983), who proposed that primitive endoderm cells required
contact with pluripotent cells of the epiblast/primitive
ectoderm for visceral endoderm instruction. Interestingly,
visceral endoderm formation was observed in extra-embryonic
cells overlying pluripotent cells of both ES and EPL cell origin
in mixed embryoid bodies. The pluripotent cell-derived signal
must therefore either be restricted to ES-derived cells and
diffusible in nature, or expressed by both ES-derived cells and
EPL-derived cells present in an ES cell embryoid body
environment. The failure of EPL-derived cells to support
visceral endoderm in EPL cell embryoid bodies may be
explained by reprogramming of EPL cells in mixed embryoid
bodies to an ES cell state, as demonstrated here and previously
(Rathjen et al., 1999).
The formation of late-stage primitive ectoderm and onset of
mesodermal differentiation was advanced in EPL cell
embryoid bodies compared to ES cell embryoid bodies,
perturbing the normal temporal relationship between primitive
endoderm and epiblast. As a result, visceral endoderm-
competent primitive endoderm cells and pluripotent cells
expressing the presumed inductive signal may not coincide
temporally. A requirement for close coupling between
pluripotent cells and primitive endoderm for visceral endoderm
formation may also explain the observation that visceral
endoderm formation is reduced in LIF-treated embryoid
bodies, where primitive ectoderm formation is inhibited
(Fisher et al., 1989; Shen and Leder, 1992). Default
differentiation of primitive endoderm into parietal endoderm,
in the absence of inductive signals and cell contacts required
for visceral endoderm formation, may underlie the observation
that isolated primitive endoderm cells predominantly form
parietal endoderm when introduced into host blastocysts
(Gardner, 1982, 1983). An understanding of the origin of
visceral endoderm is important in view of increasing evidence
pointing to the instructive ability of this cell population during
early embryogenesis (Chen et al., 1994; Spyropolus and
Capecchi, 1994; Coucouvanis and Martin, 1995; Thomas and
Beddington, 1996). The use of pluripotent cells with alternative
capacities to form visceral endoderm potentially allows
mechanistic investigation of this event.
EPL cell embryoid bodies exhibit early defects in the
formation of neural lineages
Embryoid bodies derived from EPL cells display a reduced or
absent capacity for neuron formation when compared to ES
cell embryoid bodies. However, RA differentiation of
aggregates demonstrated that ES and EPL cells were equally
competent to form neurons, consistent with the postulated
pluripotence of EPL cells. This suggests that the defect in
neuron formation in EPL embryoid bodies reflects an alteration
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in the embryoid body environment rather than a cell-
autonomous restriction in EPL differentiation ability. 
The earliest defect that we identified in EPL cell embryoid
bodies was a failure to form visceral endoderm. This suggested
that the failure of EPL cell embryoid bodies to form neurons
might be explained by perturbation of early differentiation
events. Accordingly, we analysed formation of early neural
progenitors by expression of Sox1, and demonstrated that EPL
cell embryoid bodies fail to form these cells. Embryonic Sox1
expression is first detected in ectodermal cells destined to
become neurectoderm at 7.5 d.p.c. (Pevny et al., 1998) and
persists in undifferentiated neural cells. A role for visceral
endoderm in ectoderm/neurectoderm formation has not been
demonstrated directly but is consistent with results reported by
others. For example, the visceral endodermal cell line END-2
secretes a factor which can induce differentiation of P19 EC
cells into muscle and neurons in vitro (Mummery et al., 1991;
van den Eijnden-van Raaij et al., 1991). Furthermore, the
anterior visceral endoderm has been postulated to be required
for correct molecular patterning of the rostral neurectoderm
(Thomas and Beddington, 1996; reviewed in Beddington and
Robertson, 1998). We are currently investigating the formation
of ectoderm and neurectoderm in ES and EPL cell embryoid
bodies, and the possible role of visceral endoderm in these
processes. 
EPL cells embryoid bodies exhibit increased
formation of nascent mesoderm, which can be
programmed into alternative cell fates
Mesoderm formation within ES embryoid bodies described in
this work was relatively consistent with that described by
others, despite differences in the ES cell lines and culture
conditions employed. Brachyury expression, detected by RT-
PCR, was also shown to initiate in ES cell embryoid bodies on
days 4-5 (Keller et al., 1993; Johansson and Wiles, 1995), and
cardiac muscle formation is generally detected in ES cell
embryoid bodies at day 8, with 40-60% of embryoid bodies
beating by day 12 (Doetschman et al., 1985; Sanchez et al.,
1991; Wang et al., 1992; Lints et al., 1993).
In comparison to ES cell embryoid bodies, the nascent
mesoderm-specific marker brachyury was expressed earlier
and in a greater proportion of EPL cell embryoid bodies,
consistent with the earlier onset of differentiation in these
bodies, observed both morphologically and as a reduction in
Oct4 expression. Further differentiation of EPL bodies
confirmed the enhanced mesodermal differentiation with the
appearance of terminally differentiated cells occurring earlier
and at higher levels than in ES cell embryoid bodies. The
apparent alteration in germ layer formation, in which EPL cells
showed elevated formation of mesoderm at the expense of
neurons/ectoderm, could reflect alterations in cell/cell
interactions and/or cell/extracellular matrix interactions
resulting from a lack of visceral endoderm. The importance of
visceral endoderm in cellular specification in vivo has been
repeatedly demonstrated (Beddington and Robertson, 1998).
The developmental fate of nascent mesoderm induced in
EPL cell embryoid bodies was not determined but could be
influenced by the addition of exogenous cytokines, as shown
by the enhanced formation of macrophages in embryoid bodies
cultured in the presence of IL-3 and M-CSF. This demonstrated
that the effect of MEDII on ES cells did not predispose them
to muscle formation, but increased the frequency of
differentiation into multipotent mesodermal progenitors, which
could be differentiated into alternative lineages by
manipulation of the differentiation environment. The ability to
compare differentiation within ES and EPL cell embryoid
bodies provides a system for the identification and
characterisation of signals that regulate mesodermal cell
specification. The potential to produce cell populations
enriched in mesoderm progenitor bodies also provides an
improved system for the production of mesodermal cell types
for applications such as cell-based therapy (Rathjen et al.,
1998).
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